Does Polivy Provide A Cure For DLBCL? Too Early To Say, Argue NICE Experts
A Draft 'No' To Roche’s Lymphoma Contender
Roche receives initial knockback for lymphoma treatment which could rival CAR-T therapies.
You may also be interested in...
Its ‘virus chasing’ habits has given Inovio a bad reputation. But with backing from CEPI and Bill Gates, it has a chance to prove the doubters wrong.
Investment from Janssen helps to validate the platform developed by the San Diego-based company.
Non-profit approach is reassuring for healthcare payers, but vaccines won’t be ready to stop pandemic at its peak.